Literature DB >> 19158571

Limbal stem cell deficiency arising from systemic chemotherapy with hydroxycarbamide.

Xiaoyan Ding1, Rachel J Bishop, Alexandra A Herzlich, Mrinali Patel, Chi-Chao Chan.   

Abstract

PURPOSE: The purpose of this study was to report a case of limbal stem cell deficiency (LSCD) after systemic chemotherapy with hydroxycarbamide.
METHODS: Clinical manifestations and pathology are detailed.
RESULTS: We describe the case of a woman with sickle cell disease, who developed bilateral LSCD after treatment with hydroxycarbamide. Histologic examination confirmed the diagnosis of LSCD, revealing goblet cells, inflammatory cells, deposits of new collagen components, and neovascularization in the peripheral cornea. Matrix metalloproteinase-3, fibronectin, and collagen III were also detected in the lesions.
CONCLUSIONS: The systemic use of the antineoplastic drug, hydroxycarbamide, may cause severe LSCD. We recommend that a medication history, including that of cytotoxic drugs, be considered in evaluating LSCD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19158571      PMCID: PMC2670888          DOI: 10.1097/ICO.0b013e318183a3bd

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Limbal stem cell deficiency arising from systemic chemotherapy.

Authors:  P Ellies; D F Anderson; A Topuhami; S C Tseng
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

Review 2.  Limbal stem cells of the corneal epithelium.

Authors:  H S Dua; A Azuara-Blanco
Journal:  Surv Ophthalmol       Date:  2000 Mar-Apr       Impact factor: 6.048

3.  Amniotic membrane transplantation or conjunctival limbal autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries.

Authors:  R T Pires; A Chokshi; S C Tseng
Journal:  Cornea       Date:  2000-05       Impact factor: 2.651

4.  Sickle cell anemia--basic research reaches the clinic.

Authors:  A N Schechter; G P Rodgers
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

Review 5.  Ocular surface stem cells and disease: current concepts and clinical applications.

Authors:  L P K Ang; D T H Tan
Journal:  Ann Acad Med Singapore       Date:  2004-09       Impact factor: 2.473

6.  Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.

Authors:  Blonie W Dudney; Monika A Malecha
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

7.  Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface.

Authors:  G Pellegrini; O Golisano; P Paterna; A Lambiase; S Bonini; P Rama; M De Luca
Journal:  J Cell Biol       Date:  1999-05-17       Impact factor: 10.539

  7 in total
  6 in total

1.  Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency.

Authors:  Sophie X Deng; Vincent Borderie; Clara C Chan; Reza Dana; Francisco C Figueiredo; José A P Gomes; Graziella Pellegrini; Shigeto Shimmura; Friedrich E Kruse
Journal:  Cornea       Date:  2019-03       Impact factor: 2.651

2.  Neurotrophic Keratopathy in Systemic Diseases: A Case Series on Patients Treated With rh-NGF.

Authors:  Alessandro Meduri; Giovanni William Oliverio; Antonio Valastro; Claudia Azzaro; Umberto Camellin; Francesco Franchina; Leandro Inferrera; Anna Roszkowska; Pasquale Aragona
Journal:  Front Med (Lausanne)       Date:  2022-05-30

Review 3.  The diagnosis of limbal stem cell deficiency.

Authors:  Qihua Le; Jianjiang Xu; Sophie X Deng
Journal:  Ocul Surf       Date:  2017-11-04       Impact factor: 5.033

4.  Disruption of Mks1 localization to the mother centriole causes cilia defects and developmental malformations in Meckel-Gruber syndrome.

Authors:  Cheng Cui; Bishwanath Chatterjee; Deanne Francis; Qing Yu; Jovenal T SanAgustin; Richard Francis; Terry Tansey; Charisse Henry; Baolin Wang; Bethan Lemley; Gregory J Pazour; Cecilia W Lo
Journal:  Dis Model Mech       Date:  2010-11-02       Impact factor: 5.758

5.  Corneal Epithelial Findings in Patients with Multiple Myeloma Treated with Antibody-Drug Conjugate Belantamab Mafodotin in the Pivotal, Randomized, DREAMM-2 Study.

Authors:  Asim V Farooq; Simona Degli Esposti; Rakesh Popat; Praneetha Thulasi; Sagar Lonial; Ajay K Nooka; Andrzej Jakubowiak; Douglas Sborov; Brian E Zaugg; Ashraf Z Badros; Bennie H Jeng; Natalie S Callander; Joanna Opalinska; January Baron; Trisha Piontek; Julie Byrne; Ira Gupta; Kathryn Colby
Journal:  Ophthalmol Ther       Date:  2020-07-25

6.  Limbal stem cell deficiency secondary to systemic paclitaxel (Taxol) for breast cancer: a case report.

Authors:  Amardeep Sekhon; Jeff Y F Wang; Johnson C H Tan; Simon P Holland; Sonia N Yeung
Journal:  BMC Ophthalmol       Date:  2020-10-07       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.